1 active trials 0 recruiting 1 Phase 3 1 disease areas 2 changes in 30 days
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT05172726 | Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects | Plaque Psoriasis | Active, Not Recruiting | 2026-04-17 |
Psoriasis (1)